If such an approach could regulate MIF’s immunosuppressing activity and pro-inflammatory arrangements, this would provide a therapeutic strategy if we only prevent CD74 function in antigen presentation to the immune cells in the tumor milieu. This evidence concerns the gene MIF and neoplasm.